ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET


Sareum Holdings PLC.
50 announcements.
Time Ticker Company Announcement
07:00 SAR Sareum Holdings PLC
Trading Statement
07:00 SAR Sareum Holdings PLC
Change of Adviser
14:17 SAR Sareum Holdings PLC
Sareum notes Sierra Q2 results
16:29 SAR Sareum Holdings PLC
Additional disclosure concerning Michael Owen
07:00 SAR Sareum Holdings PLC
Additional Funds Raised
13:50 SAR Sareum Holdings PLC
Sierra seeks strategic options for SRA737
07:00 SAR Sareum Holdings PLC
Successful Fundraising
16:30 SAR Sareum Holdings PLC
Placing to progress TYK2/JAK1 programmes
16:31 SAR Sareum Holdings PLC
PrimaryBid.com Offer
07:00 SAR Sareum Holdings PLC
Portfolio Update
16:00 SAR Sareum Holdings PLC
Key takeaways from SRA737 webcast at ASCO
11:05 SAR Sareum Holdings PLC
Second Price Monitoring Extn
11:00 SAR Sareum Holdings PLC
Price Monitoring Extension
07:00 SAR Sareum Holdings PLC
Positive SRA737 data presented at ASCO
07:00 SAR Sareum Holdings PLC
ASCO abstracts for SRA737 published
12:41 SAR Sareum Holdings PLC
Sareum notes Sierra Oncology Q1 2019 Results
07:00 SAR Sareum Holdings PLC
Sareum to Present at BioTrinity 2019 in London
07:00 SAR Sareum Holdings PLC
SRA737 Phase I/IIa data to be presented at ASCO
07:00 SAR Sareum Holdings PLC
Preclinical Data for SRA737 Presented at AACR 2019
07:00 SAR Sareum Holdings PLC
Sareum Holdings PLC Issue of Options
07:00 SAR Sareum Holdings PLC
HALF-YEARLY RESULTS ENDED 31 DECEMBER 2018
14:04 SAR Sareum Holdings PLC
Sierra Oncology has reported its 2018 Results
08:14 SAR Sareum Holdings PLC
New SRA737 preclin data to be presented at AACR
13:38 SAR Sareum Holdings PLC
Sierra Oncology to present SRA737 at DDR Tx Summit
12:35 SAR Sareum Holdings PLC
Results of AGM
07:00 SAR Sareum Holdings PLC
AGM Statement
11:17 SAR Sareum Holdings PLC
Amendment to Preclinical Efficacy Announcement
07:45 SAR Sareum Holdings PLC
Preclinical Efficacy for Immunotherapy Combination
10:24 SAR Sareum Holdings PLC
Preclinical Data for SRA737 in Ovarian Cancer
07:00 SAR Sareum Holdings PLC
AGM NOTICE
07:00 SAR Sareum Holdings PLC
Directorate Change
12:28 SAR Sareum Holdings PLC
Sierra Oncology Q3 2018 Results
07:00 SAR Sareum Holdings PLC
Completion of Placing
07:00 SAR Sareum Holdings PLC
FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018
13:03 SAR Sareum Holdings PLC
Notice of Results
07:00 SAR Sareum Holdings PLC
TYK2/JAK1 selected for certain cancers
07:00 SAR Sareum Holdings PLC
Pre-Close Trading Statement
07:00 SAR Sareum Holdings PLC
Selection of TYK2/JAK1 for autoimmune diseases
13:15 SAR Sareum Holdings PLC
Sareum notes Sierra Oncology Q2 2018 Results
09:38 SAR Sareum Holdings PLC
Notification of PCA Shareholding
07:00 SAR Sareum Holdings PLC
Advisers
07:00 SAR Sareum Holdings PLC
Sareum regains rights to Aurora+FLT3 inhibitors
07:00 SAR Sareum Holdings PLC
Notice of Interim Results
07:00 SAR Sareum Holdings PLC
Preclinical synergy of sra737 and PARP inhibitor
12:50 SAR Sareum Holdings PLC
Sierra Oncology expands SRA737 development program
07:00 SAR Sareum Holdings PLC
Interim Results
07:00 SAR Sareum Holdings PLC
Late-breaker abstract for SRA737 accepted for AACR
12:45 SAR Sareum Holdings PLC
AACR 2018 Update
07:00 SAR Sareum Holdings PLC
Sareum to Present at BioTrinity 2018 in London
12:21 SAR Sareum Holdings PLC
SRA737 trial update in Sierra Oncology Q1 Results